Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Is the consistency more important than the ingredients for steroid treatment in eosinophilic esophagitis?

Parrish DW, Sharma S, Kumar S.

Ann Allergy Asthma Immunol. 2014 Apr;112(4):286-9. doi: 10.1016/j.anai.2014.01.026. Epub 2014 Feb 22. No abstract available.

PMID:
24566294
2.

Eosinophilic esophagitis: treatment with oral viscous budesonide.

Zur E.

Int J Pharm Compd. 2012 Jul-Aug;16(4):288-93. Review.

PMID:
23050387
3.

Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis.

Dellon ES, Sheikh A, Speck O, Woodward K, Whitlow AB, Hores JM, Ivanovic M, Chau A, Woosley JT, Madanick RD, Orlando RC, Shaheen NJ.

Gastroenterology. 2012 Aug;143(2):321-4.e1. doi: 10.1053/j.gastro.2012.04.049. Epub 2012 May 3.

4.

Diarrhea, Ascites, and Eosinophilia.

Francis FF, Kulich SM, Hashash JG.

Gastroenterology. 2016 Apr;150(4):e6-8. doi: 10.1053/j.gastro.2015.10.019. Epub 2016 Feb 28. No abstract available.

PMID:
26930018
5.

Adrenal Suppression in Children Treated With Oral Viscous Budesonide for Eosinophilic Esophagitis.

Harel S, Hursh BE, Chan ES, Avinashi V, Panagiotopoulos C.

J Pediatr Gastroenterol Nutr. 2015 Aug;61(2):190-3. doi: 10.1097/MPG.0000000000000848.

PMID:
25950088
6.

Swallowed glucocorticoid therapy for eosinophilic esophagitis in children does not suppress adrenal function.

Philla KQ, Min SB, Hefner JN, Howard RS, Reinhardt BJ, Nazareno LG, Vogt KS.

J Pediatr Endocrinol Metab. 2015 Sep;28(9-10):1101-6. doi: 10.1515/jpem-2014-0260.

PMID:
26024243
7.

Treatment of eosinophilic esophagitis with inhaled budesonide in a 7-year-old boy with concomitant persistent asthma: resolution of esophageal submucosal fibrosis and eosinophilic infiltration.

Maples KM, Henderson SC, Graham M, Irani AM.

Ann Allergy Asthma Immunol. 2007 Dec;99(6):572-4. doi: 10.1016/S1081-1206(10)60390-0. No abstract available.

PMID:
18219842
8.

Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis.

Molina-Infante J, Martin-Noguerol E, Alvarado-Arenas M, Porcel-Carreño SL, Jimenez-Timon S, Hernandez-Arbeiza FJ.

J Allergy Clin Immunol. 2012 Nov;130(5):1200-2. doi: 10.1016/j.jaci.2012.06.027. Epub 2012 Aug 3. No abstract available.

PMID:
22867695
9.

[FEATURES OF TREATMENT OF EOSINOPHILIC ESOPHAGITIS IN SCHOOLCHILDREN].

Horodylovska MI.

Lik Sprava. 2015 Jan-Mar;(1-2):144-5. Ukrainian.

PMID:
26118052
10.

Drug treatment of eosinophilic oesophagitis.

O'Donnell S, Kelly OB, O'Morain CA.

Curr Drug Metab. 2012 Nov;13(9):1323-6. Review.

PMID:
22493987
11.

An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.

Assa'ad AH, Gupta SK, Collins MH, Thomson M, Heath AT, Smith DA, Perschy TL, Jurgensen CH, Ortega HG, Aceves SS.

Gastroenterology. 2011 Nov;141(5):1593-604. doi: 10.1053/j.gastro.2011.07.044. Epub 2011 Aug 9.

PMID:
21835135
12.

Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.

Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, Schoepfer A, Simon HU.

Clin Gastroenterol Hepatol. 2011 May;9(5):400-9.e1. doi: 10.1016/j.cgh.2011.01.017. Epub 2011 Jan 28.

PMID:
21277394
13.

Conservative long-term treatment of children with eosinophilic esophagitis.

Levine J, Lai J, Edelman M, Schuval SJ.

Ann Allergy Asthma Immunol. 2012 May;108(5):363-6. doi: 10.1016/j.anai.2012.02.024. Epub 2012 Mar 21.

PMID:
22541409
14.

Eosinophils and eosinophilic cationic protein in induced sputum and blood: effects of budesonide and terbutaline treatment.

Aldridge RE, Hancox RJ, Cowant JO, Frampton CM, Town GI, Taylor DR.

Ann Allergy Asthma Immunol. 2002 Nov;89(5):492-7.

PMID:
12452208
15.

Incidental gastric eosinophils in patients with eosinophilic esophagitis: do they matter?

Ammoury RF, Rosenman MB, Roettcher D, Gupta SK.

J Pediatr Gastroenterol Nutr. 2010 Dec;51(6):723-6. doi: 10.1097/MPG.0b013e3181d98e6c.

PMID:
20601904
16.

Eosinophilic esophagitis to unsuspected rare food allergen.

Mane SK, Jordan PA, Bahna SL.

Ann Allergy Asthma Immunol. 2013 Jul;111(1):64-5. doi: 10.1016/j.anai.2013.04.004. Epub 2013 Apr 30. No abstract available.

PMID:
23806462
17.

[A new treatment for eosinophilic esophagitis: oral viscous budenoside].

Lancho Monreal EM, Fernández Fernández S, Echeverria Zudaire L, Cilleruelo Pascual ML, Rodrigo García G.

An Pediatr (Barc). 2011 May;74(5):341-3. doi: 10.1016/j.anpedi.2011.01.004. Epub 2011 Mar 3. Spanish. No abstract available.

18.

Variable yield of allergy patch testing in children with eosinophilic esophagitis.

Paquet B, Bégin P, Paradis L, Drouin E, Des Roches A.

J Allergy Clin Immunol. 2013 Feb;131(2):613. doi: 10.1016/j.jaci.2012.10.053. Epub 2012 Dec 20. No abstract available.

PMID:
23260753
19.

[Eosinophilic oesophagitis: a frequently missed cause of dysphagia].

van Rhijn BD, Smout AJ, Bredenoord AJ.

Ned Tijdschr Geneeskd. 2012;156(23):A4716. Review. Dutch.

PMID:
22727233
20.

Adrenal Suppression in EoE Treated With Budesonide?

LeLeiko NS, Quintos JB.

J Pediatr Gastroenterol Nutr. 2015 Aug;61(2):155. doi: 10.1097/MPG.0000000000000877. No abstract available.

PMID:
26222658

Supplemental Content

Support Center